RA Capital’s $2.58M Buying Streak in Artiva Biotherapeutics (ARTV)
RA Capital Management, L.P. has been steadily adding to its stake in Artiva Biotherapeutics, Inc. (ARTV), according to a new Form 4 filed with the SEC. The latest purchase, dated July 23, 2026, shows the firm buying 59,880 shares at $9.96 apiece, a transaction worth $596,404.80. This is not an isolated trade. It’s the third … Read more